The leading medical device company for personalized spine treatments has announced FDA Approval for a groundbreaking new progression in patient-specific surgeries. NEW YORK, NY and LYON, France (April 25, 2016) – MEDICREA,® (Alternext Paris: FR0004178572 – ALMED) the only medical device company offering patient-specific implant solutions for the treatment of spinal conditions, has announced FDA

• The Healthcare Guys
• Wednesday, May 11, 2016
• 0
• Press Release
• 0
• 2.4K

To match global healthcare delivery models with sustainability and practicality, the Middle Eastern care givers are more open to invest and explore the best possible ways to move ahead and become a centre for medical tourism backed with affordable world class medical infrastructure. Investments under health informatics in the Middle East is witnessing a steady

• The Healthcare Guys
• Sunday, April 3, 2016
• 0
• Press Release
• 0
• 2.8K

UNID™ LAB SERVICES COLLABORATE WITH SPINE SURGEONS FOR PRE-OPERATIVE PLANNING, ORDER FULFILLMENT AND POST-OPERATIVE ANALYSIS; MEDICREA ACHIEVES MORE THAN 500 UNID™ SURGERIES PERFORMED WORLDWIDE Lyon and New York, March 14, 2016 – MEDICREA® (Alternext Paris: FR0004178572-ALMED), the leading medical device company for developing patient-specific solutions for the treatment of spinal conditions) has announced the groundbreaking

• The Healthcare Guys
• Sunday, April 3, 2016
• 0
• Press Release
• 0
• 2.4K